Videos

Amy Valent, DO, MCR, discusses how continuous glucose monitors and smart insulin delivery tools are reshaping individualized care for pregnant patients with diabetes.

Lisa Bayer, MD, MPH, details her presentation at the 2025 ACOG ACSM pain management during IUD placement.

Megan Wasson, DO, discusses surgical precision, imaging, and mentorship to improve endometriosis care at the 2025 ACOG Annual Meeting.

Megan Cohen, MD, MPH, outlines major changes to the CDC’s 2024 contraceptive recommendations, including updated safety classifications, inclusive language, and new guidance for transgender and medically complex patients.

Megan Wasson, DO, and Ceylan Colak, MD, highlight how imaging and multidisciplinary care improve endometriosis diagnosis, treatment, and patient outcomes at the 2025 ACOG ACSM.

In this interview at the 2025 ACOG ACSM, Johanna Finkle, MD, urged clinicians to tailor weight loss care based on BMI, contraception use, and medication risks using patient-centered counseling.

Erin Keyser, MD, FACOG, breaks down the latest approaches to hormone therapy for menopause, emphasizing personalized care and shared decision-making.

Tia Welsh, MD, MPH, FACOG, highlights how primary HPV screening, self-collection, and extended genotyping are transforming cervical cancer detection and improving access for underserved populations.

Elizabeth Evans, MD, and Deslyn Hobson, MD, highlight how non-estrogen therapies such as ospemifene can effectively manage symptoms

Despite widespread awareness of guidelines, many health care providers fall short in consistently screening and referring postpartum women for depression, putting maternal mental health at risk.

Jill Liss, MD, shares details on her presentation on the physiology of menopause care and how clinicians can use evidence to improve patient care at the 2025 ACOG ACSM.

Elizabeth Mollard, PhD, WHNP, CNM, shares her research, presented at the 2025 ACOG ACSM, on Medicaid postpartum depression (PPD) screening and coverage policies on PPD diagnosis.

Victoria Wang, MD, discusses updated ASCCP recommendations for post-treatment monitoring of high-grade dysplasia and the importance of identifying high-risk patients early.

Farah Amro, MD, shares her research at the 2025 ACOG ACSM on leaving the placenta in situ in select patients with placenta accreta spectrum.

Laurence Shields, MD, shares details from his latest study on hemorrhage control devices for postpartum hemorrhage at the 2025 ACOG ACSM.

Postpartum depression often goes undiagnosed because of a lack of screening and stigma—learn how early detection, open conversations, and new treatment options can improve outcomes for mothers.

Research highlights buprenorphine’s effectiveness and safety in improving outcomes for pregnant patients with opioid use disorder, urging updates to medical guidelines.

Devon Ramaeker, MD, dives into the expansion of prenatal genetic testing, improvements in early diagnosis of anomalies, and patient education.

A new survey of over 1000 US women highlights widespread misconceptions about perimenopause, hormone therapy, and the importance of lifestyle changes during the menopause transition.

According to Joy Windley, CLC, delayed follow-ups, lack of accessible resources, and limited support systems are leaving postpartum women vulnerable to serious health and emotional challenges.

The BRITE-MOM study at UCSF uses wearable ECGs to detect arrhythmias in pregnant women, aiming to improve early diagnosis and maternal cardiac outcomes.

A new survey highlights major gaps in fertility knowledge, emphasizing the importance of anti-müllerian hormone testing, insurance coverage awareness, and early proactive care.

Leeya Pinder, MD, MPH, highlights a national conference to spotlight the role of human papillomavirus in cancer, emphasizing vaccination, screening innovations, and collaborative efforts to eliminate cervical cancer.

A phase 3 analysis shows that estetrol with drospirenone significantly reduces menstrual pain, mood swings, and other menstrual symptoms, offering clear benefits for both new and switching contraceptive users.

Panelists discuss how environmental modifications based on patient preferences are crucial during intrauterine device (IUD) placement, including verbal comfort, adjusted lighting, distractions, and heating pads. They emphasize that physician rapport significantly impacts pain perception, acknowledging that postprocedure discomfort can last for days. They also ensure that patients receive comprehensive management guidelines and contact information for follow-up support.

A large-scale study uncovers significantly higher uterine fibroid diagnosis rates among Black, Hispanic, and Asian women compared to White women, with notable differences across Asian subgroups.

A global study uncovers the widespread stigma, emotional toll, and workplace challenges women face during menopause, highlighting the urgent need for awareness, support, and personalized care.

Discover key strategies OB-GYNs can use to protect pregnant women from severe COVID-19 risks and ensure healthier maternal outcomes.

Panelists discuss how physicians consistently underestimate intrauterine device (IUD) placement pain compared to patients’ reported experiences. They emphasize that addressing this disparity requires physician humility, community education initiatives, and adherence to standardized guidelines such as the CDC’s updated 2024 pain management recommendations.